Double digit growth expected in revenue, PAT.
Revenue from operations grew by 3% to ₹6,595 crore compared to ₹6,423 crore in the corresponding period last year.
The Board approved a second interim dividend of ₹4.50 per equity share
Mankind Pharma stock has witnessed a nearly 20 % increase in the last six months
The collaboration aims to advance renewable energy projects both domestically and internationally
This action is taken as these securities have surpassed 95% of the market-wide position limit (MWPL), as reported by the NSE
The second interim dividend is scheduled to be paid to members on March 5, 2024
According to PRIME's Pranav Haldea, insurance firms sold a net of ₹15,622 Crore.
A day before its IPO opens for subscription, Sheetal Agarwal of IIFL caught up with management of the company.
KPIL secured new orders worth ₹380 Crores in Q4 FY24, with year-to-date order inflows reaching ₹18,065 Crores
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
